Glossary

510(k) Premarket Notification

A premarket submission made to the FDA to demonstrate that a device to be marketed is substantially equivalent to a legally marketed predicate device.

Get in touch Learn more

Modern WeWork hardware lab area with product team collaborating around AI device prototypes, 3D printer in background, dramatic industrial lighting with product sketches on glass walls.

REGULATORY PATHWAY

What is 510(k) Premarket Notification?

A 510(k) Premarket Notification is a premarket submission made to the FDA to demonstrate that a medical device is substantially equivalent to a legally marketed predicate device.

A 510(k) Premarket Notification is a regulatory submission required by the U.S. Food and Drug Administration (FDA) for most Class II medical devices and select Class I devices. The submission must demonstrate that the new device is substantially equivalent (SE) to a legally marketed predicate device that does not require Premarket Approval (PMA). This equivalence is established by comparing the intended use, technological characteristics, and performance data of the new device against the predicate.

For Software as a Medical Device (SaMD), a 510(k) often requires detailed documentation of the software development lifecycle per IEC 62304, analytical validation studies, and a robust comparison of the algorithm's output to the predicate's clinical performance. The submitter must prove that any new technological features do not raise different questions of safety or effectiveness, ensuring the device is at least as safe and effective as the predicate before receiving clearance to market.

ANATOMY OF A SUBMISSION

Core Components of a 510(k)

A 510(k) Premarket Notification is a structured legal argument for substantial equivalence. Each section must provide specific, verifiable evidence that the new device is as safe and effective as a legally marketed predicate.

Substantial Equivalence (SE) Rationale

The central thesis of the entire submission. This section provides a side-by-side comparison of the new device and the chosen predicate device.

Intended Use: Must be identical or nearly identical.
Technological Characteristics: Detailed comparison of materials, design, energy source, and operating principles.
Performance Data: Summary of testing that proves differences do not raise new questions of safety or effectiveness. The goal is not to prove superiority, but to establish that the new device is a legal 'twin' of an existing, legally marketed device.

Device Description

A comprehensive narrative and visual breakdown of the device's physical and functional identity.

Hardware Specifications: Dimensions, materials, and engineering schematics for any physical components.
Software Architecture: For Software as a Medical Device (SaMD), this details the algorithm's logic, required inputs, and output formats.
Operational Flow: A step-by-step explanation of how the user interacts with the device to achieve the clinical result. This section must align precisely with the Indications for Use statement to avoid regulatory misalignment.

Performance Testing Data

The quantitative evidence backbone. This section contains the raw data and statistical analyses from bench, animal, or clinical testing.

Analytical Validation: Proves the device can accurately and reliably measure what it claims (e.g., sensitivity and specificity for a diagnostic AI).
Bench Testing: Controlled lab experiments demonstrating electrical safety, mechanical integrity, and electromagnetic compatibility (EMC).
Software Verification: Evidence that the code was developed under a Quality Management System (QMS) like ISO 13485, often referencing the IEC 62304 standard. Any test that deviates from a recognized consensus standard must be rigorously justified.

Biocompatibility Assessment

Required for any device with direct or indirect patient contact. This section evaluates the biological response to the device's materials.

ISO 10993 Series: The guiding standard for testing, covering cytotoxicity, sensitization, and irritation.
Chemical Characterization: An exhaustive analysis of leachable substances and material composition.
Gap Analysis: A documented rationale explaining why specific tests were omitted based on the nature and duration of patient contact. For purely digital SaMD products with no physical patient contact, this section is typically omitted with a clear justification statement.

Sterilization & Shelf-Life Validation

Applies to devices delivered sterile or with a defined expiration date. This section proves the device remains safe and functional until use.

Sterilization Method: Detailed description of the validated process (e.g., ethylene oxide, gamma radiation) per ISO 11135 or ISO 11137.
Package Integrity: Data proving the sterile barrier remains intact during shipping and handling.
Accelerated Aging: Protocols that simulate real-time aging to validate the labeled shelf life, ensuring device performance does not degrade over time. This section is critical for single-use surgical instruments and implantable components.

Labeling & User Interface

The FDA reviews all proposed labeling to ensure it is not false or misleading. This includes more than just the physical label.

Instructions for Use (IFU): The detailed clinical manual for safe operation.
Human Factors Engineering (HFE): A summary report proving that the user interface minimizes use-related hazards, as per the FDA's guidance on applying ISO 14971.
On-Screen Displays: For SaMD, every screen, alert, and error message is considered part of the labeling and must be submitted for review. The labeling must strictly reflect the cleared Intended Use; off-label promotion is prohibited.

REGULATORY CLARIFICATIONS

Frequently Asked Questions

Clear, technically precise answers to the most common questions about the 510(k) premarket notification process for Software as a Medical Device (SaMD).

A 510(k) Premarket Notification is a legally mandated submission to the U.S. Food and Drug Administration (FDA) demonstrating that a new medical device is substantially equivalent (SE) to a legally marketed predicate device that does not require Premarket Approval (PMA). It is required for most Class II devices and select Class I devices that are not exempt, serving as a clearance pathway rather than an approval. For Software as a Medical Device (SaMD), a 510(k) is necessary when the software performs a diagnostic function—such as analyzing radiological images to detect lesions—that is substantially equivalent to an existing, legally marketed software tool. The submission must include a detailed comparison of the new device's intended use and technological characteristics against the predicate, supported by performance testing data. If the FDA determines the device is substantially equivalent, it issues a clearance order, permitting commercial distribution. The statutory requirement derives from Section 510(k) of the Federal Food, Drug, and Cosmetic Act, and the process typically requires 90 days for FDA review, though actual timelines often extend due to iterative requests for additional information.

REGULATORY PATHWAY COMPARISON

510(k) vs. De Novo vs. PMA

A comparison of the three primary FDA premarket submission pathways for medical devices, including Software as a Medical Device (SaMD).

Feature	510(k) Premarket Notification	De Novo Classification Request	Premarket Approval (PMA)
Device Class	Class II (and some Class I)	Class I or II (novel devices)	Class III
Risk Profile	Moderate risk	Low to moderate risk	High risk
Predicate Device Required
Regulatory Standard	Substantial Equivalence (SE)	Special Controls (risk-based)	Safety and Effectiveness
Typical Review Time	90 days (FDA goal)	150 days (FDA goal)	180 days (FDA goal)
Clinical Data Requirement	Often not required; bench testing	Usually required	Always required (clinical trials)
Submission Fee (FY2024 Small Business)	$5,447	$5,447	$121,248
Post-Market Requirements	Special controls, QMS, MDR	Special controls, QMS, MDR	Post-approval study, PMSR, QMS, MDR

Enabling Efficiency, Speed & Accuracy

Intelligent Analysis, Decision & Execution

We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.

Talk to Us

Search across company data

Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.

Useful when people spend too long searching or get different answers from different systems.

Enterprise searchRAGPermissions

Automate internal workflows

Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.

Useful when repetitive work moves across multiple tools and teams.

AI agentsWorkflow automationGovernance

Add AI to products and internal tools

Build assistants, guided actions, or decision support into the software your team or customers already use.

Useful when AI needs to be part of the product, not a separate tool.

AI integrationDecision supportModel routing

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.

Limited slotsGet a Free AI Consultation

How We Work

Custom AI workflows for your Business

One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.

Talk to Us

510(k) Premarket Notification

What is 510(k) Premarket Notification?